GUNALDI, M. Et Al. 2014. The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology , (Illinois, United States Of America).

GUNALDI, M., ERKISI, M., AFSAR, C. U., ERCOLAK, V., Paydas, S., Kara, I. O., ... Sahin, B.(2014). The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment. . 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America

GUNALDI, ÜMRAN Et Al. "The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 2014

GUNALDI, ÜMRAN K. Et Al. "The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America, 2014

GUNALDI, M. Et Al. (2014) . "The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={ÜMRAN KÜÇÜKGÖZ GÜLEÇ Et Al. }, title={The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment.}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Illinois}, country={United States Of America}, year={2014}}